Kozłowski, M.; Michalczyk, K.; Witczak, G.; Kwiatkowski, S.; Mirecka, A.; Nowak, K.; Pius-Sadowska, E.; Machaliński, B.; Cymbaluk-Płoska, A.
Evaluation of Paraoxonase-1 and Pentraxin-3 in the Diagnosis and Prognosis of Endometrial Cancer. Antioxidants 2022, 11, 2024.
https://doi.org/10.3390/antiox11102024
AMA Style
Kozłowski M, Michalczyk K, Witczak G, Kwiatkowski S, Mirecka A, Nowak K, Pius-Sadowska E, Machaliński B, Cymbaluk-Płoska A.
Evaluation of Paraoxonase-1 and Pentraxin-3 in the Diagnosis and Prognosis of Endometrial Cancer. Antioxidants. 2022; 11(10):2024.
https://doi.org/10.3390/antiox11102024
Chicago/Turabian Style
Kozłowski, Mateusz, Kaja Michalczyk, Grzegorz Witczak, Sebastian Kwiatkowski, Aneta Mirecka, Katarzyna Nowak, Ewa Pius-Sadowska, Bogusław Machaliński, and Aneta Cymbaluk-Płoska.
2022. "Evaluation of Paraoxonase-1 and Pentraxin-3 in the Diagnosis and Prognosis of Endometrial Cancer" Antioxidants 11, no. 10: 2024.
https://doi.org/10.3390/antiox11102024
APA Style
Kozłowski, M., Michalczyk, K., Witczak, G., Kwiatkowski, S., Mirecka, A., Nowak, K., Pius-Sadowska, E., Machaliński, B., & Cymbaluk-Płoska, A.
(2022). Evaluation of Paraoxonase-1 and Pentraxin-3 in the Diagnosis and Prognosis of Endometrial Cancer. Antioxidants, 11(10), 2024.
https://doi.org/10.3390/antiox11102024
